Dr. Hope Rugo and advocate Jonise Louis discuss new ADCs, biomarker testing, and patient-centered dosing for metastatic ...
Association of immune, proliferation gene signatures and stromal tumor infiltrating lymphocytes (sTILs) with outcomes in patients with stage I triple-negative breast cancer (TNBC). This is an ASCO ...
This article was medically reviewed by Lisa Richards, MSN, CNM, who offers health services at Ovia Health. Triple-negative breast cancer is an aggressive cancer that's primarily treated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results